Subject: | |
From: | |
Reply To: | |
Date: | Tue, 5 Apr 2011 14:14:55 -0400 |
Content-Type: | multipart/alternative |
Parts/Attachments: |
|
|
> *Dissertation Defense Announcement:
> To: The George Mason University Community*
>
> *Tony Pierson
> PhD Biosciences Candidate
> *
> *Date: Thursday April 7, 2011
> Time: 11:30 a.m.
> Place: George Mason University
> ** Bull Run Hall, Room 249
> Prince William campus <http://www.gmu.edu/resources/visitors/findex.html>
>
> Dissertation Chair: Dr. Monique van Hoek
> Committee members: Dr. Charles L. Bailey, Dr. Calvin Carpenter, Dr. Barney Bishop*
> *Title: "Specific and Innate Immunity Against Francisella"*
>
> The dissertation is on reserve in the Johnson Center Library, Fairfax campus.The doctoral project will not be read at the meeting, but should be read in advance.
>
>
> /**/All members of the George Mason University community are invited
> to attend.
>
> /ABSTRACT:/
>
> /Francisella tularensis/ is a highly infectious gram negative
> bacterium which causes tularemia.
>
> /Francisella/ produces outer membrane vesicles (OMVs), which release
> many proteins into the extracellular proteome. We successfully
> demonstrate that a novel /Francisella/ OMV vaccine delivered
> intranasally protects BALB/C mice challenged with up to 100 LD50 of
> intranasally delivered /Francisella/. Next we demonstrate that
> mutations in the Tol/Pal system in /Francisella/ results in OMV
> over-production. This finding may lead to a method of producing larger
> amounts of OMVs for future vaccine production. Next, we measured
> changes in transcription of well characterized as well as novel human
> ? defensin (hBD) genes upon exposure to /Francisella/. We observed
> increased induction of transcription of hBDs when compared to the
> negative control. To demonstrate translation, we used ELISA and found
> that the amount of hBD protein in supernatant from each treatment
> group was significantly higher than the negative control. We also
> visualized hBD2 colocalized with /Francisella/. Together, these
> finding demonstrate that hBDs are stimulated by and associated with
> /Francisella/ bacteria as well as their OMVs. Finally, we showed that
> hBDs stimulate the production of OMVs /in vitro/. Taken together, this
> research establishes that OMVs stimulate the innate as well as
> specific immunity in a manner similar to whole bacteria. However, OMVs
> are acellular, and as such represent a novel vaccine candidate which
> is capable of stimulating both innate and specific immunity.
>
> ###
>
>
>
|
|
|